Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

BBRY Stock: BlackBerry SecuTablet Can’t Save This Dog

BlackBerry (BBRY) stock won't get a spark from the BlackBerry SecuTablet, an awkwardly named tablet for gov't and enterprise customers.

Valeant Shareholders May Lose in the Salix ‘Win’ (VRX, SLXP, ENDP)

Valeant Pharmaceuticals (VRX) swiped Salix Pharmaceuticals (SLXP) from Endo International (ENDP), but was it really worth it?

3 Stocks to Sell as PC Sales Crumble

Pare your exposure to these three stocks -- which will each suffer as PC sales fall -- or risk pressuring returns indefinitely.

6 Capital Markets Stocks to Sell Now

For the current week, the overall ratings of six capital markets stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Awful Sales Growth — RNA EXAS GNCA NBIX TENX

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

3 Tech Services Stocks to Sell Now

The overall ratings of three tech services stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

12 Metals and Mining Stocks to Sell Now

This week, the overall grades of 12 metals and mining stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Media Stocks to Sell Now

The ratings of three media stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Medical Devices Stocks to Sell Now

This week, the ratings of three medical devices stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Bad Operating Margin Growth — CTEL WIFI KEG TWGP HXM

This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Mega-Cap Tech Stocks to Sell

Energy stocks led the way, but now a number of large-cap tech stocks are succumbing to selling pressure, too. Here are five to sell before things get worse.

Herbalife (HLF) Stock Still Toxic Despite Manipulation Probe

Herbalife (HLF) stock may have been manipulated by people with connections to hedge-fund manager Bill Ackman. The stock is a sell regardless.

5 Stocks With Crummy Analyst Earnings Revisions — REXX TLM KEG LONG ASYS

This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

9 Machinery Stocks to Sell Now

The ratings of nine machinery stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

10 Internet and Web Service Stocks to Sell Now

This week, the ratings of 10 internet and web service stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Chemicals Stocks to Sell Now

For the current week, the overall ratings of four chemicals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Bank of America Keeps Stressing Out (BAC)

Results of Bank of America's stress test once again slowed the amount and rate of cash returns to shareholders, hurting BAC stock.

5 Construction and Engineering Stocks to Sell Now

For the current week, the overall ratings of five construction and engineering stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Sell Shake Shack (SHAK) Stock After Earnings Whiff

SHAK stock got slammed Thursday after missing EPS estimates in its first-ever earnings report as a public company. Sell SHAK and buy its rivals.